| Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT M Wiesmüller, HH Quick, B Navalpakkam, MM Lell, M Uder, P Ritt, ... European journal of nuclear medicine and molecular imaging 40, 12-21, 2013 | 140 | 2013 |
| 68Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer C Schmidkonz, M Cordes, D Schmidt, T Bäuerle, TI Goetz, M Beck, ... European Journal of Nuclear Medicine and Molecular Imaging 45, 1862-1872, 2018 | 120 | 2018 |
| Longitudinal analysis of bone metabolism using SPECT/CT and 99mTc-diphosphono-propanedicarboxylic acid: comparison of visual and quantitative analysis M Beck, JC Sanders, P Ritt, J Reinfelder, T Kuwert EJNMMI research 6, 1-9, 2016 | 84 | 2016 |
| 99mTc‐MIP‐1404‐SPECT/CT for the detection of PSMA‐positive lesions in 225 patients with biochemical recurrence of prostate cancer C Schmidkonz, C Hollweg, M Beck, J Reinfelder, TI Goetz, JC Sanders, ... The Prostate 78 (1), 54-63, 2018 | 79 | 2018 |
| SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer C Schmidkonz, M Cordes, M Beck, TI Goetz, D Schmidt, O Prante, ... Clinical nuclear medicine 43 (4), 225-231, 2018 | 49 | 2018 |
| First Experience With SPECT/CT Using a 99mTc-Labeled Inhibitor for Prostate-Specific Membrane Antigen in Patients With Biochemical Recurrence of Prostate Cancer J Reinfelder, T Kuwert, M Beck, JC Sanders, P Ritt, C Schmidkonz, ... Clinical Nuclear Medicine 42 (1), 26-33, 2017 | 49 | 2017 |
| Individual calculation of effective dose and risk of malignancy based on Monte Carlo simulations after whole body computed tomography M Kopp, T Loewe, W Wuest, M Brand, M Wetzl, W Nitsch, D Schmidt, ... Scientific Reports 10 (1), 9475, 2020 | 19 | 2020 |
| Multimodal imaging of bone metastases: From preclinical to clinical applications S Ellmann, M Beck, T Kuwert, M Uder, T Bäuerle Journal of Orthopaedic Translation 3 (4), 166-177, 2015 | 19 | 2015 |
| Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate Cancer C Schmidkonz, M Cordes, M Beck, TI Goetz, D Schmidt, O Prante, ... Clinical nuclear medicine 43 (8), e250-e258, 2018 | 18 | 2018 |
| Using power watersheds to segment benign thyroid nodules in ultrasound image data E Kollorz, E Angelopoulou, M Beck, D Schmidt, T Kuwert Bildverarbeitung für die Medizin 2011: Algorithmen-Systeme-Anwendungen …, 2011 | 13 | 2011 |
| Positron emission tomography–computed tomography versus positron emission tomography–magnetic resonance imaging for diagnosis of oral squamous cell carcinoma: A pilot study T Schlittenbauer, M Zeilinger, E Nkenke, S Kreißel, MC Wurm, M Lell, ... Journal of Cranio-Maxillofacial Surgery 43 (10), 2129-2135, 2015 | 11 | 2015 |
| 99mTc-MIP-1404 SPECT/CT for Patients With Metastatic Prostate Cancer: Interobserver and Intraobserver Variability in Treatment-Related Longitudinal Tracer Uptake Assessments of … C Schmidkonz, A Atzinger, TI Goetz, M Beck, P Ritt, O Prante, T Kuwert, ... Clinical Nuclear Medicine 45 (2), 105-112, 2020 | 10 | 2020 |
| F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: Preliminary single-center analysis … M Beck, J Hartwich, M Eckstein, D Schmidt, AO Gostian, S Müller, ... Annals of Nuclear Medicine 36 (7), 623-633, 2022 | 6 | 2022 |
| Dissimilar DNA Damage to Blood Lymphocytes After 177Lu-Labeled DOTATOC or Prostate-Specific Membrane Antigen Therapy P Ritt, C Jobic, M Beck, C Schmidkonz, T Kuwert, M Uder, M Brand Journal of Nuclear Medicine 62 (3), 379-385, 2021 | 5 | 2021 |
| Repeating of local therapy of distant metastases increases overall survival in patients with synchronous metastasized rectal cancer—a monocentric analysis M Haderlein, S Lettmaier, M Langheinrich, A Schmid, S Semrau, M Hecht, ... International Journal of Colorectal Disease 33, 1533-1541, 2018 | 2 | 2018 |
| Tc-99-MIP-1404 Imaging for the Detection of PSMA-Positive Lesions. A Pilot Study in 380 Patients with Histologically Confirmed Prostate Cancer C Schmidkonz, P Ritt, C Hollweg, M Beck, T Goetz, J Sanders, ... EANM'17, 2017 | 2 | 2017 |
| Wertigkeit der SPECT/CT in der skelettszintigrafischen Diagnostik M Beck, T Kuwert Der Nuklearmediziner 39 (01), 8-21, 2016 | 2 | 2016 |
| First experience with PSMA-SPECT/CT using a 99mTc-labeled PSMA inhibitor for patients with biochemical recurrence of prostate cancer J Reinfelder, T Kuwert, O Prante, B Wullich, P Hennig, M Beck, J Sanders, ... Journal of Nuclear Medicine 56 (supplement 3), 67-67, 2015 | 2 | 2015 |
| Differences and Similarities in the Pattern of Early Metabolic and Morphologic Response after Induction Chemo-Immunotherapy versus Induction Chemotherapy Alone in Locally … M Beck, S Semrau, M Haderlein, AO Gostian, J Hartwich, S Müller, ... Cancers 14 (19), 4811, 2022 | 1 | 2022 |
| Quantitative Analysis of Multimodal Skeletal SPECT/CT Reconstructions in Diagnosing Medication-related Osteonecrosis of the Jaw MT Beck, G Rugel, J Reinfelder, T Kuwert, P Ritt, S Kreissel, ... Nuklearmedizin-NuclearMedicine, 2021 | 1 | 2021 |
Philipp RittHead of Imaging & Dosimetry, ITM Isotope Technologies Munich SE, GermanyVerified email at itm-radiopharma.com
